CVS Group (LON:CVSG)‘s stock had its “buy” rating reiterated by research analysts at Peel Hunt in a research report issued to clients and investors on Thursday, September 27th.
Separately, Royal Bank of Canada upgraded shares of CVS Group to an “outperform” rating and reduced their price target for the company from GBX 1,230 ($16.07) to GBX 1,190 ($15.55) in a report on Monday, August 20th.
LON CVSG traded up GBX 1 ($0.01) on Thursday, reaching GBX 806 ($10.53). The company had a trading volume of 436,342 shares, compared to its average volume of 234,115. CVS Group has a 12 month low of GBX 13.22 ($0.17) and a 12 month high of GBX 1,500 ($19.60).
About CVS Group
CVS Group plc provides veterinary services in the United Kingdom. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste collection services for veterinary practices and directly for pet owners.
Featured Article: Calculate Your Return on Investment (ROI)
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.